These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
538 related items for PubMed ID: 12956448
1. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases. Aksoy Y, Oral A, Aksoy H, Demirel A, Akcay F. Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448 [Abstract] [Full Text] [Related]
2. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer]. Iwaki H, Kajita Y, Shimizu Y, Yamauchi T. Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957 [Abstract] [Full Text] [Related]
4. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen. Uno H, Koide T, Kuriyama M, Ban Y, Deguchi T, Kawada Y. Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060 [Abstract] [Full Text] [Related]
8. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men. Ghafoori M, Varedi P, Hosseini SJ, Asgari M, Shakiba M. Urol J; 2009 Jul; 6(3):182-8. PubMed ID: 19711272 [Abstract] [Full Text] [Related]
10. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer]. Meguro N, Maeda O, Saiki S, Kinouchi T, Kuroda M, Usami M, Kotake T. Hinyokika Kiyo; 1998 Sep; 44(9):639-43. PubMed ID: 9805668 [Abstract] [Full Text] [Related]
11. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL. Castro HAS, Iared W, Santos JEM, Solha RS, Shigueoka DC, Ajzen SA. Int Braz J Urol; 2018 Sep; 44(4):709-716. PubMed ID: 29697929 [Abstract] [Full Text] [Related]
13. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL. Terakawa T, Miyake H, Kanomata N, Kumano M, Takenaka A, Fujisawao M. Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081 [Abstract] [Full Text] [Related]
14. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence. Rahardjo D, Kamil ST, Pakasi LS. Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211 [Abstract] [Full Text] [Related]
16. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection. Chiang IN, Chang SJ, Pu YS, Huang KH, Yu HJ, Huang CY. Urol Int; 2009 May; 82(3):270-5. PubMed ID: 19440012 [Abstract] [Full Text] [Related]
19. [The usefulness of percentage of free prostate specific antigen/prostate specific antigen density in the diagnosis of prostate cancer]. Han G, Gao JP, Cao XL, Hong BF, Tang J. Zhonghua Wai Ke Za Zhi; 2006 Mar 15; 44(6):379-81. PubMed ID: 16638346 [Abstract] [Full Text] [Related]
20. Prostate cancer detection by prostate-specific antigen-related parameters. Segawa N, Gohji K, Iwamoto Y, Ueda H, Katsuoka Y. Hinyokika Kiyo; 2003 Jul 15; 49(7):405-10. PubMed ID: 12968483 [Abstract] [Full Text] [Related] Page: [Next] [New Search]